ArticleBMC medical imaging2026
Non-invasive prediction of B-cell lymphoma-2 and Ki-67 expression in primary central nervous system lymphoma using whole-tumor histogram analysis of diffusion weighted imaging, diffusional kurtosis imaging and intravoxel incoherent motion.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo evaluate and compare the diagnostic performance of whole-tumor histogram analysis using multiple diffusion MRI models for prediction of B-cell lymphoma-2 (BCL-2) and Ki-67 expression in PCNSL.
methodsEighty-one participants who underwent conventional diffusion weighted imaging (DWI), diffusional kurtosis imaging (DKI), and intravoxel incoherent motion (IVIM) examinations between January 2020 and January 2025 were enrolled in this study. Whole-tumor histogram features extracted from apparent diffusion coefficient (ADC), diffusion coefficient (Dk), diffusional kurtosis (K), pure diffusion coefficient (D), pseudo-diffusion coefficient (D*), and perfusion fraction (f) maps were compared between different BCL-2 and Ki-67 expression groups using Mann-Whitney U test. Receiver operating characteristic (ROC) analysis and logistic regression analysis were used to evaluate the diagnostic performance of different diffusion models. Internal validation was performed using bootstrap resampling with 1000 repetitions.
resultsA total of 21 and 26 histogram features derived from diffusion maps were identified as effective for distinguishing different BCL-2 and Ki-67 expression statuses in PCNSL (all P < 0.05), respectively. Among the DWI, DKI, IVIM, and combined models, no significant differences were observed in the areas under the receiver operating characteristic curves (AUCs) for predicting BCL-2 expression (AUCs (95%CI): 0.810 (0.683-0.903), 0.830 (0.706-0.917), 0.901 (0.798-1.000), and 0.877 (0.769-0.984), respectively; all corrected P > 0.05, Bonferroni correction) or Ki-67 index (AUCs (95%CI): 0.832 (0.732-0.906), 0.769 (0.662-0.856), 0.792 (0.688-0.874), and 0.824 (0.724-0.900), respectively; all corrected P > 0.05, Bonferroni correction) in PCNSL. Bootstrap internal validation suggested limited model optimism and acceptable calibration.
conclusionsWhole-tumor histogram analysis based on diffusion MRI is an effective noninvasive method for predicting BCL-2 expression and Ki-67 index in PCNSL. No statistically significant difference was detected among the three diffusion models in this preliminary study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.